{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T03:28:13Z","timestamp":1765596493469,"version":"3.48.0"},"reference-count":39,"publisher":"Pharmaceutical Society of Japan","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,12,9]]},"DOI":"10.1248\/bpb.b25-00447","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:09:06Z","timestamp":1765231746000},"page":"1887-1896","source":"Crossref","is-referenced-by-count":0,"title":["Coagulation and Fibrinolysis Profiles in Mouse Breast Cancer 4T1 Tumor-Bearing Mice: A Characterization of Neutrophil-Associated Prothrombotic States"],"prefix":"10.1248","volume":"48","author":[{"given":"Riyo","family":"Morimoto-Kamata","sequence":"first","affiliation":[{"name":"Laboratory of Host Defense, Teikyo University, 2\u201311\u20131 Kaga, Itabashi-ku, Tokyo 173\u20138605, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Munakata","sequence":"additional","affiliation":[{"name":"Laboratory of Drug and Gene Delivery Research, Teikyo University, 2\u201311\u20131 Kaga, Itabashi-ku, Tokyo 173\u20138605, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Kageyama","sequence":"additional","affiliation":[{"name":"Laboratory of Theranostics, Faculty of Pharmaceutical Science, Teikyo University, 2\u201311\u20131 Kaga, Itabashi-ku, Tokyo 173\u20138605, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Laboratory of Theranostics, Faculty of Pharmaceutical Science, Teikyo University, 2\u201311\u20131 Kaga, Itabashi-ku, Tokyo 173\u20138605, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Laboratory of Drug and Gene Delivery Research, Teikyo University, 2\u201311\u20131 Kaga, Itabashi-ku, Tokyo 173\u20138605, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Kamikubo","sequence":"additional","affiliation":[{"name":"Thrombo Translational Research Lab Inc., 3\u201314\u20133 Minamikumamoto, Chuo-ku, Kumamoto 860\u20130812, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Ohkura","sequence":"additional","affiliation":[{"name":"Laboratory of Host Defense, Teikyo University, 2\u201311\u20131 Kaga, Itabashi-ku, Tokyo 173\u20138605, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Bray F, Laversanne M, Weiderpass E, Soerjomataram I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. <i>Cancer<\/i>, <b>127<\/b>, 3029\u20133030 (2021).","DOI":"10.1002\/cncr.33587"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Khorana AA, Ahrendt SA, Ryan CK, Francis CW, Hruban RH, Hu YC, Hostetter G, Harvey J, Taubman MB. Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer. <i>Clin. Cancer Res.<\/i>, <b>13<\/b>, 2870\u20132875 (2007).","DOI":"10.1158\/1078-0432.CCR-06-2351"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Mulder FI, Horv\u00e1th-Puh\u00f3 E, van Es N, van Laarhoven HWM, Pedersen L, Moik F, Ay C, B\u00fcller HR, S\u00f8rensen HT. Venous thromboembolism in cancer patients: a population-based cohort study. <i>Blood<\/i>, <b>137<\/b>, 1959\u20131969 (2021).","DOI":"10.1182\/blood.2020007338"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Abdol Razak NB, Jones G, Bhandari M, Berndt MC, Metharom P. Cancer-associated thrombosis: an overview of mechanisms, risk factors, and treatment. <i>Cancers<\/i>, <b>10<\/b>, 380 (2018).","DOI":"10.3390\/cancers10100380"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Khorana AA, Mackman N, Falanga A, Pabinger I, Noble S, Ageno W, Moik F, Lee AYY. Cancer-associated venous thromboembolism. <i>Nat. Rev. Dis. Primers<\/i>, <b>8<\/b>, 11 (2022).","DOI":"10.1038\/s41572-022-00336-y"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Hisada Y, Mackman N. Mechanisms of cancer-associated thrombosis. <i>Res. Pract. Thromb. Haemost.<\/i>, <b>7<\/b>, 100123 (2023).","DOI":"10.1016\/j.rpth.2023.100123"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Leal AC, Mizurini DM, Gomes T, Rochael NC, Saraiva EM, Dias MS, Werneck CC, Sielski MS, Vicente CP, Monteiro RQ. Tumor-derived exosomes induce the formation of neutrophil extracellular traps: implications for the establishment of cancer-associated thrombosis. <i>Sci. Rep.<\/i>, <b>7<\/b>, 6438 (2017).","DOI":"10.1038\/s41598-017-06893-7"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Hisada Y, Mackman N. Tissue factor and cancer: regulation, tumor growth, and metastasis. <i>Semin. Thromb. Hemost.<\/i>, <b>45<\/b>, 385\u2013395 (2019).","DOI":"10.1055\/s-0039-1687894"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Hisada Y, Mackman N. Tissue factor and extracellular vesicles: activation of coagulation and impact on survival in cancer. <i>Cancers<\/i> (Basel), <b>13<\/b>, 3839 (2021).","DOI":"10.3390\/cancers13153839"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kubala MH, DeClerck YA. The plasminogen activator inhibitor-1 paradox in cancer: a mechanistic understanding. <i>Cancer Metastasis Rev.<\/i>, <b>38<\/b>, 483\u2013492 (2019).","DOI":"10.1007\/s10555-019-09806-4"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Sillen M, Declerck PJ. A narrative review on plasminogen activator inhibitor-1 and its (patho)physiological role: to target or not to target? <i>Int. J. Mol. Sci.<\/i>, <b>22<\/b>, 2721 (2021).","DOI":"10.3390\/ijms22052721"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. <i>Nat. Rev. Immunol.<\/i>, <b>18<\/b>, 134\u2013147 (2018).","DOI":"10.1038\/nri.2017.105"},{"key":"13","unstructured":"13) American Cancer Society. \u201cBreast Cancer Facts &amp; Figures 2024\u20132025.\u201d Atlanta: American Cancer Society; &lt;https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/breast-cancer-facts-and-figures\/2024\/breast-cancer-facts-and-figures-2024.pdf&gt;, accessed 14 April, 2025."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Hu Z, Shen R, Campbell A, McMichael E, Yu L, Ramaswamy B, London CA, Xu T, Carson WE 3rd. Targeting tissue factor for immunotherapy of triple-negative breast cancer using a second-generation ICON. <i>Cancer Immunol. Res.<\/i>, <b>6<\/b>, 671\u2013684 (2018).","DOI":"10.1158\/2326-6066.CIR-17-0343"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Ren Z, Xue Y, Liu L, Zhang X, Pei J, Zhang Y, Wang Y, Yu K. Tissue factor overexpression in triple-negative breast cancer promotes immune evasion by impeding T-cell infiltration and effector function. <i>Cancer Lett.<\/i>, <b>565<\/b>, 216221 (2023).","DOI":"10.1016\/j.canlet.2023.216221"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Demers M, Krause DS, Schatzberg D, Martinod K, Voorhees JR, Fuchs TA, Scadden DT, Wagner DD. Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>109<\/b>, 13076\u201313081 (2012).","DOI":"10.1073\/pnas.1200419109"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Asakura H. Classifying types of disseminated intravascular coagulation: clinical and animal models. <i>J. Intensive Care<\/i>, <b>2<\/b>, 20 (2014).","DOI":"10.1186\/2052-0492-2-20"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Berthelsen LO, Kristensen AT, Tranholm M. Animal models of DIC and their relevance to human DIC: a systematic review. <i>Thromb. Res.<\/i>, <b>128<\/b>, 103\u2013116 (2011).","DOI":"10.1016\/j.thromres.2010.12.002"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Bain BL. <i>Blood cells: a practical guide<\/i>. 3rd ed., John Wiley &amp; Sons, Chichester (2021).","DOI":"10.1002\/9781119820307"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Morimoto-Kamata R, Matsuki S, Ohkura N, Yui S. Cathepsin G-induced cell aggregation of breast cancer MCF-7 decreases doxorubicin sensitivity in a hypoxia-inducible factor-independent mechanism. <i>Biol. Pharm. Bull.<\/i>, <b>45<\/b>, 1772\u20131783 (2022).","DOI":"10.1248\/bpb.b22-00447"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Morimoto-Kamata R, Ohkura N. Paclitaxel and vinblastine increase plasminogen activator inhibitor-1 production in human breast cancer MCF-7 cells but not MDA-MB-231 cells. <i>Biol. Pharm. Bull.<\/i>, <b>47<\/b>, 1494\u20131503 (2024).","DOI":"10.1248\/bpb.b24-00291"},{"key":"22","unstructured":"22) Aslakson CJ, Miller FR. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. <i>Cancer Res.<\/i>, <b>52<\/b>, 1399\u20131405 (1992)."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Tao K, Fang M, Alroy J, Sahagian GG. Imagable 4T1 model for the study of late stage breast cancer. <i>BMC Cancer<\/i>, <b>8<\/b>, 228 (2008).","DOI":"10.1186\/1471-2407-8-228"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Stewart LK, Kline JA. Metabolic syndrome increases risk of venous thromboembolism recurrence after acute deep vein thrombosis. <i>Blood Adv.<\/i>, <b>4<\/b>, 127\u2013135 (2020).","DOI":"10.1182\/bloodadvances.2019000561"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Aksu K, Donmez A, Keser G. Inflammation-induced thrombosis: mechanisms, disease associations and management. <i>Curr. Pharm. Des.<\/i>, <b>18<\/b>, 1478\u20131493 (2012).","DOI":"10.2174\/138161212799504731"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Luyendyk JP, Schoenecker JG, Flick MJ. The multifaceted role of fibrinogen in tissue injury and inflammation. <i>Blood<\/i>, <b>133<\/b>, 511\u2013520 (2019).","DOI":"10.1182\/blood-2018-07-818211"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Heyes H, Mohr W, Theiss W. Fibrin deposition and removal in disseminated intravascular coagulation induced by endotoxin and saline loading: radioautographic findings in rats. <i>Thromb. Haemost.<\/i>, <b>40<\/b>, 499\u2013511 (1979).","DOI":"10.1055\/s-0038-1648683"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Gomes T, V\u00e1rady CBS, Louren\u00e7o AL, Mizurini DM, Rondon AMR, Leal AC, Gon\u00e7alves BS, Bou-Habib DC, Medei E, Monteiro RQ. IL-1\u03b2 blockade attenuates thrombosis in a neutrophil extracellular trap-dependent breast cancer model. <i>Front. Immunol.<\/i>, <b>10<\/b>, 2088 (2019).","DOI":"10.3389\/fimmu.2019.02088"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Uno K, Homma S, Satoh T, Nakanishi K, Abe D, Matsumoto K, Oki A, Tsunoda H, Yamaguchi I, Nagasawa T, Yoshikawa H, Aonuma K. Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer. <i>Br. J. Cancer<\/i>, <b>96<\/b>, 290\u2013295 (2007).","DOI":"10.1038\/sj.bjc.6603552"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Abu Saadeh F, Norris L, O\u2019Toole S, Mohamed BM, Langhe R, O\u2019Leary J, Gleeson N. Tumor expression of tissue factor and tissue factor pathway inhibitor in ovarian cancer-relationship with venous thrombosis risk. <i>Thromb. Res.<\/i>, <b>132<\/b>, 627\u2013634 (2013).","DOI":"10.1016\/j.thromres.2013.09.016"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Sakurai M, Matsumoto K, Gosho M, Sakata A, Hosokawa Y, Tenjimbayashi Y, Katoh T, Shikama A, Komiya H, Michikami H, Tasaka N, Akiyama-Abe A, Nakao S, Ochi H, Onuki M, Minaguchi T, Yoshikawa H, Satoh T. Expression of tissue factor in epithelial ovarian carcinoma is involved in the development of venous thromboembolism. <i>Int. J. Gynecol. Cancer<\/i>, <b>27<\/b>, 37\u201343 (2017).","DOI":"10.1097\/IGC.0000000000000848"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Sachetto ATA, Mackman N. Monocyte tissue factor expression: lipopolysaccharide induction and roles in pathological activation of coagulation. <i>Thromb. Haemost.<\/i>, <b>123<\/b>, 1017\u20131033 (2023).","DOI":"10.1055\/a-2091-7006"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Martin KR, Wong HL, Witko-Sarsat V, Wicks IP. G-CSF\u2014a double edge sword in neutrophil mediated immunity. <i>Semin. Immunol.<\/i>, <b>54<\/b>, 101516 (2021).","DOI":"10.1016\/j.smim.2021.101516"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Granger JM, Kontoyiannis DP. Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients: a retrospective, single-institution study. <i>Cancer<\/i>, <b>115<\/b>, 3919\u20133923 (2009).","DOI":"10.1002\/cncr.24480"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Karagiannidis I, Salataj E, Said Abu Egal E, Beswick EJ. G-CSF in tumors: aggressiveness, tumor microenvironment and immune cell regulation. <i>Cytokine<\/i>, <b>142<\/b>, 155479 (2021).","DOI":"10.1016\/j.cyto.2021.155479"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Hollm\u00e9n M, Karaman S, Schwager S, Lisibach A, Christiansen AJ, Maksimow M, Varga Z, Jalkanen S, Detmar M. G-CSF regulates macrophage phenotype and associates with poor overall survival in human triple-negative breast cancer. <i>OncoImmunology<\/i>, <b>5<\/b>, e1115177 (2015).","DOI":"10.1080\/2162402X.2015.1115177"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Wada H, Takahashi H, Uchiyama T, Eguchi Y, Okamoto K, Kawasugi K, Madoiwa S, Asakura H. The approval of revised diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. <i>Thromb. J.<\/i>, <b>15<\/b>, 17 (2017).","DOI":"10.1186\/s12959-017-0142-4"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Iba T, Levi M, Thachil J, Helms J, Scarlatescu E, Levy JH. Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis on sepsis-induced coagulopathy in the management of sepsis. <i>J. Thromb. Haemost.<\/i>, <b>21<\/b>, 145\u2013153 (2023).","DOI":"10.1016\/j.jtha.2022.10.022"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Hisada Y, Garratt KB, Maqsood A, Grover SP, Kawano T, Cooley BC, Erlich J, Moik F, Flick MJ, Pabinger I, Mackman N, Ay C. Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancer. <i>Blood Adv.<\/i>, <b>5<\/b>, 487\u2013495 (2021).","DOI":"10.1182\/bloodadvances.2020003149"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/12\/48_b25-00447\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T03:26:39Z","timestamp":1765596399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/12\/48_b25-00447\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00447","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"type":"print","value":"0918-6158"},{"type":"electronic","value":"1347-5215"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"article-number":"b25-00447"}}